$KLTR Cashflow Statement | Understand Stock

$KLTR

$1.47 +$0.07 (5.0%) Close

$KLTR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization
Stock-based compensation expenses
Amortization of deferred contract acquisition and fulfillment costs
Change in valuation of warrants to purchase preferred and common stock
Non-cash interest income, net
Non-cash expenses with respect to stockholders’ loans
Loss on sale of property and equipment
Gain on foreign exchange
Changes in operating assets and liabilities:
Decrease in trade receivables
Decrease (Increase) in prepaid expenses and other current assets and other assets, noncurrent
Increase in deferred contract acquisition and fulfillment costs
Increase in trade payables
Increase (Decrease) in trade payables
Increase in accrued expenses and other current liabilities
Increase (Decrease) in employees and payroll accruals
Increase (Decrease) in other liabilities, noncurrent
Increase (Decrease) in deferred revenue
Operating lease right-of-use assets and lease liabilities, net

Net cash provided by (used in) operating activities
Cash flows from investing activities:
Investment in available-for-sale marketable securities
Proceeds from maturities of available-for-sale marketable securities
Net cash acquired in business combination
Purchases of property and equipment
Proceeds from sale of property and equipment
Payments for businesses acquired, net of acquired cash
Capitalized internal-use software development costs
Investment in restricted bank deposit
Purchase of intangible assets
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Proceeds from initial public offering, net of underwriting discounts and commissions
Payment related to the conversion of Series F redeemable convertible preferred stock upon initial public offering
Proceeds from long-term loans
Repayment of long-term loans
Principal payments on finance leases
Proceeds from exercise of stock options
Cash settlement of equity classified share-based payment awards
Payment of debt issuance costs
Repurchase of common stock
Payments on account of repurchase of common stock
Net cash provided by (used in) financing activities
Effect of exchange rate changes on cash, cash equivalents and restricted cash
Net decrease in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at the beginning of the year
Cash, cash equivalents and restricted cash at the end of the year
Supplemental disclosure of non-cash activity:
Purchase of property, equipment, internal-use software, and intangible asset in credit
Purchase of property and equipment by capital lease
Lease liabilities arising from right-of-use assets
Capitalized stock-based compensation cost
Issuance of common shares and warrants with respect to the business combination
Pending proceeds from option exercises
Lease incentive recognized as leasehold improvements
Conversion of warrants to common stock upon initial public offering
Conversion of convertible and redeemable convertible preferred stock to common stock upon initial public offering
Issuance of ordinary shares and warrant with respect to business combination
Unpaid deferred offering costs

Supplemental disclosure of cash flow information
Cash paid for income taxes, net
Cash paid for interest
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheet
Cash and cash equivalents
Restricted cash included in other assets, noncurrent

Comments